Clinical Trial of Bile Etiology,Proteomics and Metabonomics of Malignant Biliary Obstruction
We will obtain bile sample for culture and susceptibility ,proteomics metabonomics test
after PTBD. Also get the blood and urine samples.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
YU HAI PENG, MD
Principal Investigator
Tianjin Medical University Cancer Institute and Hospital
China: Food and Drug Administration
TMU-CIH-IR-001
NCT01073514
December 2009
December 2013
Name | Location |
---|